SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-18-003682
Filing Date
2018-03-29
Accepted
2018-03-29 16:45:53
Documents
81
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2017_wizepharmainc.htm 10-K 1847911
2 THIRD AMENDMENT TO EXCLUSIVE DISTRIBUTION AND LICENSING AGREEMENT BY AND BETWEEN f10k2017ex10-43_wizepharma.htm EX-10.43 65335
3 MEMORANDUM OF UNDERSTANDING BY AND BETWEEN WIZE PHARMA LTD. AND RESDEVCO RESEARC f10k2017ex10-44_wizepharma.htm EX-10.44 43524
4 CERTIFICATION f10k2017ex31-1_wizepharma.htm EX-31.1 16211
5 CERTIFICATION f10k2017ex31-2_wizepharma.htm EX-31.2 16326
6 CERTIFICATION f10k2017ex32-1_wizepharma.htm EX-32.1 8174
7 CERTIFICATION f10k2017ex32-2_wizepharma.htm EX-32.2 8013
8 GRAPHIC img_001.jpg GRAPHIC 13149
  Complete submission text file 0001213900-18-003682.txt   7188266

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE wizp-20171231.xml EX-101.INS 1395921
10 XBRL SCHEMA FILE wizp-20171231.xsd EX-101.SCH 61442
11 XBRL CALCULATION FILE wizp-20171231_cal.xml EX-101.CAL 38117
12 XBRL DEFINITION FILE wizp-20171231_def.xml EX-101.DEF 186053
13 XBRL LABEL FILE wizp-20171231_lab.xml EX-101.LAB 471980
14 XBRL PRESENTATION FILE wizp-20171231_pre.xml EX-101.PRE 334916
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52545 | Film No.: 18723520
SIC: 2834 Pharmaceutical Preparations